Letter | Published:

Induction of Circulating Interferon by Synthetic Anionic Polymers of Known Composition

Naturevolume 214pages416417 (1967) | Download Citation

Subjects

Abstract

RECENTLY, it has been demonstrated that interferon production can be stimulated by a variety of microorganisms other than virus (richettsia1, trachoma inclusion conjunctivitis agents2, pleuropneumonia-like organism (J. Younger and W. Stinebring, personal communication), bacteria3, protozoa4,5) and various derivatives of living materials including endotoxin6,7, phytohaemagglutinin8, and fungal extracts9,10. Only one is of denned structure—the antibiotic, cyclohexamide11. Unfortunately, the amount of this antibiotic required for interferon production results in irreversible inhibition of protein synthesis leading to death of the animal. Recently, Regelson described antiviral activity appearing in sera of mice injected with synthetic anionic copolymers of defined composition and suggested such activity might be interferon12. This communication confirms his findings, characterizes this antiviral activity, identifies it as interferon, and explores certain of the structural requirements for copolymers to act as interferon inducers. The significance of these compounds is increased by the previous report of their activity as inhibitors of virus induced leukaemia in mice and their present trials in the therapy of human neoplasms12.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hopps, H. E., Kohno, S., Kohno, M., and Smadel, J. E., Bact. Proceed., 115 (1964).

  2. 2

    Merigan, T. C., and Hanna, L., Proc. Soc. Expt. Biol. Med., 122, 421 (1966).

  3. 3

    Youngner, J. S., and Strinebring, W. R., Science, 144, 1022 (1964).

  4. 4

    Rytel, M., and Jones, T., Proc. Soc. Expt. Biol. Med., 123, 162 (1966).

  5. 5

    Freshman, M., Merigan, T. C., Remington, J., and Brownlee, I., Proc. Soc. Expt. Biol. Med., 123, 167 (1966).

  6. 6

    Stinebring, W. R., and Youngner, J. S., Nature, 204, 712 (1964).

  7. 7

    Ho, M., Science, 146, 1472 (1964).

  8. 8

    Wheelock, E. F., Science, 149, 310 (1965).

  9. 9

    Kleinschmidt, W. J., Cline, J. C., and Murphy, E. B., Proc. U.S. Nat. Acad. Sci., 52, 741 (1964).

  10. 10

    Rytel, M. W., Shope, R. E., and Kilbornne, E. D., J. Expt. Med., 123, 577 (1966).

  11. 11

    Youngner, J. S., Stinebring, W. R., and Taube, S. E., Virology, 27, 541 (1965).

  12. 12

    Regelson, W., Proc. Intern. Symp. on Atherosclerosis and Reticuloendothelial Systems, Lake Como, Italy (in the press) (1966).

  13. 13

    Merigan, T. C., Science, 145, 811 (1964).

  14. 14

    Taylor, J., Biochem. Biophys. Res. Comm., 14, 447 (1964).

  15. 15

    Lockhart, R. L., Biochem. Biophys. Res. Comm., 15, 513 (1964).

  16. 16

    Friedman, R. M., and Sonnabend, J. A., Nature, 203, 366 (1964).

  17. 17

    Levine, S., Virology, 24, 586 (1964).

  18. 18

    Merigan, T. C., and Kleinschmidt, W. J., Nature, 208, 667 (1965).

  19. 19

    Hallum, J. V., Youngner, J. S., and Stinebring, W. R., Virology, 27, 965 (1965).

Download references

Author information

Affiliations

  1. Division of Infectious Disease, Department of Medicine, Stanford University School of Medicine, Palo Alto, California

    • T. C. MERIGAN

Authors

  1. Search for T. C. MERIGAN in:

About this article

Publication history

Received

Revised

Issue Date

DOI

https://doi.org/10.1038/214416a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.